A Business Standard article reports that the Board of Directors in India’s third largest pharmaceuticals company, Lupin, appointed Chairman D.B. Gupta’s daughter, Vinita Gupta as CEO and his son, Nilesh Gupta as Managing Director. Nilesh Gupta has replaced the existing managing director, Kamal K Sharma,  who has been promoted to the position of vice-chairman.

Vinita Gupta played a key role in the company’s revenue growth from the US market. She has a graduate degree in pharmacy from the University of Mumbai and a master’s degree in business administration from the J.L. Kellogg Graduate School of Management.

Homegrown pharma companies are seeing the new generation of leadership coming up. Last year, Samina Vaziralli, daughter of Cipla’s joint managing director, M.K. Hameid, was inducted into the Cipla management.

Read the Business Standard report here.